What Genpro Research does

Genpro Research presents a fundamental identity conflict in the source data. Firmographic records describe a Waltham, Massachusetts-based company founded in 2016 with 101–250 employees, providing solutions in biostatistics and programming, medical writing, and regulatory submissions — i.e., a clinical research / life-sciences services firm. Against this, the only verifiable primary-source footprint, the domain genproresearch.com, is an India-targeted informational and casino-review portal branded "Aviator Game India." The site publishes game-mechanic explanations, ranked casino listings (1Win, Parimatch, Mostbet, Pin-Up, Betway, Bluechip), betting-range guidance in INR (deposits ₹500–₹2,000, max bet ₹35,000), and standard Responsible Gaming and Privacy Policy pages. No CRO clients, clinical research deliverables, or life-sciences service artifacts are visible anywhere in the record.

Operationally, what is observable is a single-product content portal with one core "product" (the Aviator Game India guide), one distribution surface (the WordPress-based website), and a stated geographic focus on South Asia. Leadership is partially captured: Anoop P Ambika is listed as Chief Executive Officer, and Lodovico Parmegiani is listed as Director / IVF Laboratory Director — a title inconsistent with either the CRO description or the gambling-portal description, reinforcing ambiguity about which business is real. No revenue, funding, pricing, customer logos, partnerships, or growth metrics are disclosed for either interpretation of the business.

Because the site is the only externally verifiable artifact, an analyst cannot treat the firmographic CRO description as confirmed. The defensible reading is that the legal entity behind the domain currently operates a thin affiliate-style content portal in the Indian online-gambling information vertical, while firmographic claims about CRO services and headcount remain unverified by any first-party evidence in the dataset.

Name

Genpro Research

Legal name

Aviator Game India

Website

https://genproresearch.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Genpro Research operates genproresearch.com, an India-focused informational and casino-review portal for the Spribe Aviator crash-style gambling game; firmographic records also describe CRO services in biostatistics, medical writing, and regulatory submissions, but no first-party evidence supports that business.

Ownership category

akta.pro rank

Headquarters

HQ city

Waltham

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations

Core offering

Genpro Research operates an India-focused online content portal (DBA: Aviator Game India) that publishes guides, reviews, strategies, and responsible-gaming information covering the Spribe Aviator crash-style gambling game and Indian-friendly casino operators. The portal reviews payment options (UPI, Paytm, Google Pay), deposit/withdrawal minimums, bonuses, and game mechanics for players in India rather than selling any standalone product, subscription, or software.

Product overview

Genpro Research operates the Aviator Game India informational portal (genproresearch.com), a single-focus content platform providing guidance, strategies, and casino reviews for the Spribe Aviator crash game. The site features sub-pages including a Privacy Policy and Responsible Gaming guide. The offering consists of one core informational product with no modular architecture or additional services.

Differentiator

Problem solved

Functional benefit

Products and services

• Aviator Game India Portal Online informational and review portal targeting Indian consumers of the Spribe Aviator crash-style gambling game, covering game mechanics, betting strategies, payment methods (UPI, Paytm, Google Pay), licensed-operator reviews (1Win, Parimatch, Mostbet, Pin-Up, Betway, Bluechip), and responsible-gaming guidance.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights3 records

Direct peers

• Medpace: Medpace is a mid-sized, full-service CRO with strong biostatistics and regulatory affairs offerings, headquartered in the US Midwest. It is a good size and operating-model analog to a 101–250 employee specialized CRO serving biotech sponsors.
• Parexel International: Parexel is a global CRO with deep biostatistics, medical writing, and regulatory submission capabilities serving biopharma sponsors. Directly comparable to Genpro Research's stated CRO service mix, although substantially larger and part of a full-service clinical operations portfolio.
• Premier Research: Premier Research is a mid-sized, PE-owned CRO specializing in biotech and rare disease with biostatistics and regulatory expertise. Closely comparable size, ownership profile, and therapeutic mix to Genpro Research's stated positioning.
• ICON plc: ICON is a top-three global CRO providing biostatistics, regulatory, and medical writing services alongside clinical trial operations. It is closely comparable on functional service mix and serves the same mid-to-large biopharma sponsor base as Genpro Research claims to serve.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized, private-equity-backed CRO with strong biostatistics, medical writing, and regulatory expertise focused on CNS, oncology, and rare disease. Comparable in scale to Genpro Research and directly competes for similar mid-sized biopharma program work.

Broad incumbents

• IQVIA: IQVIA is the world's largest CRO and life sciences services firm, with industry-leading biostatistics, regulatory, and real-world evidence capabilities. It competes with Genpro Research's stated service lines at the largest end of the sponsor market and sets pricing benchmarks in the space.
• PPD (Pharmaceutical Product Development): PPD, acquired by Thermo Fisher Scientific, is a top-five global CRO with comprehensive biostatistics, regulatory affairs, and medical writing capabilities. Represents the upper-tier incumbent that defines competitive intensity in Genpro Research's stated service categories.
• Syneos Health (now private): Syneos Health is a large global CRO and commercial services provider offering biostatistics and regulatory services as part of its clinical development portfolio. Recently taken private, it represents the type of scaled player Genpro Research must compete against in winning outsourced biopharma services work.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/genproresearch
• LinkedInlinkedin.com/company/genproresearch

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genpro Research